Actinium Announces Voting Results from Its Annual Shareholder Meeting

Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced the voting results from its annual general meeting of the Company's shareholders which was held on Monday, December 23, 2013.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131230005128&newsLang=en&ndmConfigId=1000639&vnsId=41